Eintrag weiter verarbeiten
Current tools available for the diagnosis of drug-resistant tuberculosis
Gespeichert in:
| Zeitschriftentitel: | Therapeutic Advances in Infectious Disease |
|---|---|
| Personen und Körperschaften: | , , |
| In: | Therapeutic Advances in Infectious Disease, 3, 2016, 6, S. 145-151 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
SAGE Publications
|
| Schlagwörter: |
| author_facet |
Gilpin, Christopher Korobitsyn, A. Weyer, K. Gilpin, Christopher Korobitsyn, A. Weyer, K. |
|---|---|
| author |
Gilpin, Christopher Korobitsyn, A. Weyer, K. |
| spellingShingle |
Gilpin, Christopher Korobitsyn, A. Weyer, K. Therapeutic Advances in Infectious Disease Current tools available for the diagnosis of drug-resistant tuberculosis Pharmacology (medical) Infectious Diseases |
| author_sort |
gilpin, christopher |
| spelling |
Gilpin, Christopher Korobitsyn, A. Weyer, K. 2049-9361 2049-937X SAGE Publications Pharmacology (medical) Infectious Diseases http://dx.doi.org/10.1177/2049936116673553 <jats:p> Drug-resistant tuberculosis (DR-TB) poses a major threat to control of tuberculosis worldwide. Diagnosis and treatment of DR-TB are considerably more difficult than for drug-susceptible tuberculosis (TB) and require higher level infrastructure and proficiency from laboratory specialists and clinicians. The World Health Organization (WHO) End TB Strategy calls for early diagnosis and initiation of appropriate treatment of all persons of all ages with any form of drug-susceptible TB or DR-TB. This requires ensuring access to WHO-recommended rapid diagnostics and universal drug susceptibility testing (DST) for all persons with signs and symptoms of TB. There are a number of laboratory tools available for diagnosis of DR-TB, including phenotypic culture-based DST as well as molecular methods. Optimal and complementary use of the available diagnostic tools at the different levels of the tiered network of TB laboratories, as well as correct interpretation of the diagnostic results provided by them is critical for accurate and timely diagnosis of DR-TB thus enabling effective treatment and care of patients. </jats:p> Current tools available for the diagnosis of drug-resistant tuberculosis Therapeutic Advances in Infectious Disease |
| doi_str_mv |
10.1177/2049936116673553 |
| facet_avail |
Online Free |
| finc_class_facet |
Chemie und Pharmazie Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8yMDQ5OTM2MTE2NjczNTUz |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8yMDQ5OTM2MTE2NjczNTUz |
| institution |
DE-D161 DE-Zwi2 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
| imprint |
SAGE Publications, 2016 |
| imprint_str_mv |
SAGE Publications, 2016 |
| issn |
2049-9361 2049-937X |
| issn_str_mv |
2049-9361 2049-937X |
| language |
English |
| mega_collection |
SAGE Publications (CrossRef) |
| match_str |
gilpin2016currenttoolsavailableforthediagnosisofdrugresistanttuberculosis |
| publishDateSort |
2016 |
| publisher |
SAGE Publications |
| recordtype |
ai |
| record_format |
ai |
| series |
Therapeutic Advances in Infectious Disease |
| source_id |
49 |
| title |
Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_unstemmed |
Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_full |
Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_fullStr |
Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_full_unstemmed |
Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_short |
Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_sort |
current tools available for the diagnosis of drug-resistant tuberculosis |
| topic |
Pharmacology (medical) Infectious Diseases |
| url |
http://dx.doi.org/10.1177/2049936116673553 |
| publishDate |
2016 |
| physical |
145-151 |
| description |
<jats:p> Drug-resistant tuberculosis (DR-TB) poses a major threat to control of tuberculosis worldwide. Diagnosis and treatment of DR-TB are considerably more difficult than for drug-susceptible tuberculosis (TB) and require higher level infrastructure and proficiency from laboratory specialists and clinicians. The World Health Organization (WHO) End TB Strategy calls for early diagnosis and initiation of appropriate treatment of all persons of all ages with any form of drug-susceptible TB or DR-TB. This requires ensuring access to WHO-recommended rapid diagnostics and universal drug susceptibility testing (DST) for all persons with signs and symptoms of TB. There are a number of laboratory tools available for diagnosis of DR-TB, including phenotypic culture-based DST as well as molecular methods. Optimal and complementary use of the available diagnostic tools at the different levels of the tiered network of TB laboratories, as well as correct interpretation of the diagnostic results provided by them is critical for accurate and timely diagnosis of DR-TB thus enabling effective treatment and care of patients. </jats:p> |
| container_issue |
6 |
| container_start_page |
145 |
| container_title |
Therapeutic Advances in Infectious Disease |
| container_volume |
3 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792328432567189510 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T12:53:09.082Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Current+tools+available+for+the+diagnosis+of+drug-resistant+tuberculosis&rft.date=2016-12-01&genre=article&issn=2049-937X&volume=3&issue=6&spage=145&epage=151&pages=145-151&jtitle=Therapeutic+Advances+in+Infectious+Disease&atitle=Current+tools+available+for+the+diagnosis+of+drug-resistant+tuberculosis&aulast=Weyer&aufirst=K.&rft_id=info%3Adoi%2F10.1177%2F2049936116673553&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792328432567189510 |
| author | Gilpin, Christopher, Korobitsyn, A., Weyer, K. |
| author_facet | Gilpin, Christopher, Korobitsyn, A., Weyer, K., Gilpin, Christopher, Korobitsyn, A., Weyer, K. |
| author_sort | gilpin, christopher |
| container_issue | 6 |
| container_start_page | 145 |
| container_title | Therapeutic Advances in Infectious Disease |
| container_volume | 3 |
| description | <jats:p> Drug-resistant tuberculosis (DR-TB) poses a major threat to control of tuberculosis worldwide. Diagnosis and treatment of DR-TB are considerably more difficult than for drug-susceptible tuberculosis (TB) and require higher level infrastructure and proficiency from laboratory specialists and clinicians. The World Health Organization (WHO) End TB Strategy calls for early diagnosis and initiation of appropriate treatment of all persons of all ages with any form of drug-susceptible TB or DR-TB. This requires ensuring access to WHO-recommended rapid diagnostics and universal drug susceptibility testing (DST) for all persons with signs and symptoms of TB. There are a number of laboratory tools available for diagnosis of DR-TB, including phenotypic culture-based DST as well as molecular methods. Optimal and complementary use of the available diagnostic tools at the different levels of the tiered network of TB laboratories, as well as correct interpretation of the diagnostic results provided by them is critical for accurate and timely diagnosis of DR-TB thus enabling effective treatment and care of patients. </jats:p> |
| doi_str_mv | 10.1177/2049936116673553 |
| facet_avail | Online, Free |
| finc_class_facet | Chemie und Pharmazie, Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8yMDQ5OTM2MTE2NjczNTUz |
| imprint | SAGE Publications, 2016 |
| imprint_str_mv | SAGE Publications, 2016 |
| institution | DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
| issn | 2049-9361, 2049-937X |
| issn_str_mv | 2049-9361, 2049-937X |
| language | English |
| last_indexed | 2024-03-01T12:53:09.082Z |
| match_str | gilpin2016currenttoolsavailableforthediagnosisofdrugresistanttuberculosis |
| mega_collection | SAGE Publications (CrossRef) |
| physical | 145-151 |
| publishDate | 2016 |
| publishDateSort | 2016 |
| publisher | SAGE Publications |
| record_format | ai |
| recordtype | ai |
| series | Therapeutic Advances in Infectious Disease |
| source_id | 49 |
| spelling | Gilpin, Christopher Korobitsyn, A. Weyer, K. 2049-9361 2049-937X SAGE Publications Pharmacology (medical) Infectious Diseases http://dx.doi.org/10.1177/2049936116673553 <jats:p> Drug-resistant tuberculosis (DR-TB) poses a major threat to control of tuberculosis worldwide. Diagnosis and treatment of DR-TB are considerably more difficult than for drug-susceptible tuberculosis (TB) and require higher level infrastructure and proficiency from laboratory specialists and clinicians. The World Health Organization (WHO) End TB Strategy calls for early diagnosis and initiation of appropriate treatment of all persons of all ages with any form of drug-susceptible TB or DR-TB. This requires ensuring access to WHO-recommended rapid diagnostics and universal drug susceptibility testing (DST) for all persons with signs and symptoms of TB. There are a number of laboratory tools available for diagnosis of DR-TB, including phenotypic culture-based DST as well as molecular methods. Optimal and complementary use of the available diagnostic tools at the different levels of the tiered network of TB laboratories, as well as correct interpretation of the diagnostic results provided by them is critical for accurate and timely diagnosis of DR-TB thus enabling effective treatment and care of patients. </jats:p> Current tools available for the diagnosis of drug-resistant tuberculosis Therapeutic Advances in Infectious Disease |
| spellingShingle | Gilpin, Christopher, Korobitsyn, A., Weyer, K., Therapeutic Advances in Infectious Disease, Current tools available for the diagnosis of drug-resistant tuberculosis, Pharmacology (medical), Infectious Diseases |
| title | Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_full | Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_fullStr | Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_full_unstemmed | Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_short | Current tools available for the diagnosis of drug-resistant tuberculosis |
| title_sort | current tools available for the diagnosis of drug-resistant tuberculosis |
| title_unstemmed | Current tools available for the diagnosis of drug-resistant tuberculosis |
| topic | Pharmacology (medical), Infectious Diseases |
| url | http://dx.doi.org/10.1177/2049936116673553 |